Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry

Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry

© 2016 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd Aim: To evaluate and compare the retention rate of biological disease-modifying antirheumatic drugs (bDMARDs) in real-life practice and identify risk factors related to remission and drug discontin...

Saved in:

書目詳細資料
Main Authors:	Pongthorn Narongroeknawin, Parawee Chevaisrakul, Nuntana Kasitanon, Tasanee Kitumnuaypong, Ajanee Mahakkanukrauh, Boonjing Siripaitoon, Wanruchada Katchamart
格式:	雜誌
出版:	2018
主題:	Medicine
在線閱讀:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84996602311&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/59055
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!
機構:	Chiang Mai University

相似書籍

Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry
由: Pongthorn Narongroeknawin, et al.
出版: (2019)

Effectiveness and Drug Survival of Anti-Tumor Necrosis Factor Therapies in Patients with Spondyloarthritis: Analysis from the Thai Rheumatic Disease Prior Authorization Registry
由: Praveena Chiowchanwisawakit, et al.
出版: (2019)

2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis
由: Worawit Louthrenoo, et al.
出版: (2018)

2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis
由: Worawit Louthrenoo, et al.
出版: (2018)

Rate and causes of noncompliance with disease-modifying antirheumatic drug regimens in patients with rheumatoid arthritis
由: Wanruchada Katchamart, et al.
出版: (2020)

Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis
由: Wanruchada Katchamart, et al.
出版: (2018)

Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association
由: Wanruchada Katchamart, et al.
出版: (2018)

Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association
由: Wanruchada Katchamart, et al.
出版: (2018)

Budget Impact of Sequential Treatment with Biologics, Biosimilars, and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Thai Patients with Rheumatoid Arthritis
由: Manathip Osiri, et al.
出版: (2022)

Regulatory T Cell Suppressive Activity Predicts Disease Relapse During Disease-Modifying Anti-rheumatic Drug Dose Reduction in Rheumatoid Arthritis: A Prospective Cohort Study
由: Korawit Kanjana, et al.
出版: (2020)

Disease activity is associated with cognitive impairment in patients with rheumatoid arthritis
由: Wanruchada Katchamart, et al.
出版: (2020)

Validation of the Thai version of the questionnaire for identifying subjects with potential rheumatic diseases
由: Jirachaya Chaisurote, et al.
出版: (2018)

Clinical manifestations, clinical course, and outcomes of immunoglobulin G4-related disease
由: Kamonchanok Phaopraphat, et al.
出版: (2020)

Clinical manifestations, clinical course, and outcomes of immunoglobulin G4-related disease
由: Kamonchanok Phaopraphat, et al.
出版: (2020)

Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: A systematic review and meta-analysis
由: W. Katchamart, et al.
出版: (2018)

Periodontal disease in Thai patients with rheumatoid arthritis
由: Nuttapong Khantisopon, et al.
出版: (2018)

Periodontal disease in Thai patients with rheumatoid arthritis
由: Nuttapong Khantisopon, et al.
出版: (2018)

Cross-cultural adaptation and validation of the Thai version of the Rheumatoid Arthritis Disease Activity Index (RADAI)
由: Wanruchada Katchamart, et al.
出版: (2018)

Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity
由: Prawjaeng J.
出版: (2023)

Periodontal disease in Thai patients with rheumatoid arthritis
由: Khantisopon N., et al.
出版: (2014)

Periodontal disease in Thai patients with rheumatoid arthritis
由: Khantisopon N., et al.
出版: (2014)

Cost-Utility Analysis of Biologic Disease-Modifying Antirheumatic Drugs for Patients With Psoriatic Arthritis in Thailand
由: Dilokthornsakul P.
出版: (2023)

Cost-Utility Analysis of Biologic Disease-Modifying Antirheumatic Drugs for Patients With Psoriatic Arthritis in Thailand
由: Dilokthornsakul P.
出版: (2023)

Cost-Utility Analysis of Biologic Disease-Modifying Antirheumatic Drugs for Patients With Psoriatic Arthritis in Thailand
由: Dilokthornsakul P.
出版: (2023)

Cost-Utility Analysis of Biologic Disease-Modifying Antirheumatic Drugs for Patients With Psoriatic Arthritis in Thailand
由: Dilokthornsakul P.
出版: (2023)

Cost-Utility Analysis of Biologic Disease-Modifying Antirheumatic Drugs for Patients With Psoriatic Arthritis in Thailand
由: Dilokthornsakul P.
出版: (2023)

Prevalence of and factors associated with depression and anxiety in patients with rheumatoid arthritis: A multicenter prospective cross-sectional study
由: Wanruchada Katchamart, et al.
出版: (2020)

Factors associated with and cutoff points for Patient Acceptable Symptom State (PASS) in rheumatoid arthritis
由: Wanruchada Katchamart, et al.
出版: (2020)

A musculoskeletal ultrasound program as an intervention to improve disease modifying anti-rheumatic drugs adherence in rheumatoid arthritis: a randomized controlled trial
由: YK Tan, et al.
出版: (2022)

Prevalence of rheumatic disease in HIV infected Thai patients
由: Praveena Chiowchanwisawakit, et al.
出版: (2018)

Kaposi's sarcoma in rheumatic diseases
由: Louthrenoo W., et al.
出版: (2014)

Development of an in-vitro rheumatoid arthritis (RA) model and its application in anti-rheumatic drug testing
由: Tan, Kian Siong
出版: (2016)

Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis
由: Wanruchada Katchamart, et al.
出版: (2018)

Metabolic syndrome is associated with disease activity in patients with rheumatoid arthritis
由: Pongchirat Tantayakom, et al.
出版: (2018)

Clinical spectrums and outcomes of necrotizing autoimmune myopathy versus other idiopathic inflammatory myopathies: a multicenter case-control study
由: Khemmapop Yongchairat, et al.
出版: (2020)

Sicca symptoms in Thai patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma: A comparison with age-matched controls and correlation with disease variables
由: Suparaporn Wangkaew, et al.
出版: (2018)

The association between 10-year fracture risk by FRAX and osteoporotic fractures with disease activity in patients with rheumatoid arthritis
由: Ratanapha Phuan-udom, et al.
出版: (2019)

Primer on the Rheumatic Diseases
出版: (2017)

Ocular diseases in patients with rheumatic diseases
由: Ausayakhun S., et al.
出版: (2014)

Acute rheumatic fever in adults: Case report together with an analysis of 25 patients with acute rheumatic fever
由: Nuntana Kasitanon, et al.
出版: (2018)